Cancer: Extreme Pain on Movement Terminated Phase 3 Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0079795 (Cancer: Extreme Pain on Movement)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02591017Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain OutpatientsTreatment